Phibro CEO sells 18,608 shares from May 5 to May 7, 2026
Phibro Animal Health Corporation’s CEO, Jack Bendheim, sold 18,608 shares of Common Stock in multiple open-market transactions.
The transactions occurred from May 5, 2026, through May 7, 2026, with a weighted average price of $54.61.
The sales were executed under a Rule 10b5-1 trading plan adopted on December 11, 2025, and reduced Bendheim’s indirect holdings by 24.89%.
Bendheim still holds 16,840 shares directly and 56,152 shares indirectly, as well as 449,485 Class A Common Stock shares.